FIB-4 Index

Optimal result: 0 – 1.29 index

If the FIB-4 Index levels are increased, it suggests a higher probability of significant liver fibrosis or cirrhosis. This elevated score is a clinical signal that warrants further investigation and possibly more comprehensive diagnostic procedures. The implications of an increased FIB-4 score include:

→ Further Diagnostic Evaluation: Patients may require additional tests such as elastography (like FibroScan), which measures liver stiffness, or even a liver biopsy, which is the gold standard for assessing liver fibrosis.

→ Monitoring and Management of Liver Disease: Elevated FIB-4 levels often lead to closer monitoring of liver health and potential management changes, especially in chronic liver diseases like hepatitis C or NAFLD.

→ Assessment of Disease Progression: An increased FIB-4 score can indicate progression in liver disease, necessitating a reassessment of the therapeutic approach and management of underlying conditions contributing to liver damage.

→ Risk Stratification: Patients with higher scores may be at greater risk for complications related to liver fibrosis, such as portal hypertension, liver failure, or hepatocellular carcinoma, underscoring the need for vigilant clinical surveillance.

It is crucial for healthcare providers to interpret FIB-4 scores in the context of the individual patient’s overall clinical picture, including other laboratory findings, imaging results, and clinical symptoms. In some cases, consultation with a hepatologist or a liver specialist may be recommended for a more nuanced approach to management and treatment.

If your FIB-4 Index result shows an Indeterminate risk for advanced liver fibrosis, it means that your score falls within a range where the risk of significant liver scarring (fibrosis) is uncertain. This does not confirm or rule out advanced liver fibrosis but suggests that further testing may be needed for a more definitive assessment.

Understanding FIB-4 Index

The FIB-4 Index is a non-invasive biomarker used to estimate liver fibrosis risk. It is calculated using age, AST (aspartate aminotransferase), ALT (alanine aminotransferase), and platelet count. The score is typically interpreted with the following cutoffs:

  • Low Risk: FIB-4 < 1.3 (unlikely to have advanced fibrosis)
  • Indeterminate Risk: FIB-4 between 1.3 and 2.67 (uncertain risk)
  • High Risk: FIB-4 > 2.67 (higher likelihood of advanced fibrosis)

What an Indeterminate Result Means

  • Your FIB-4 score is neither clearly low nor high, meaning that advanced liver fibrosis cannot be ruled out.
  • This result may be due to age, mild liver enzyme abnormalities, or borderline platelet counts.
  • It does not necessarily mean you have liver disease, but further evaluation is recommended.

Next Steps

If your FIB-4 result falls in the indeterminate range, your healthcare provider may:

  • Order additional tests, such as the FibroScan (elastography), liver biopsy, or more advanced fibrosis markers (e.g., ELF test, APRI score).
  • Monitor your liver health over time with repeat FIB-4 testing and blood work.
  • Evaluate potential causes of liver injury, including fatty liver disease (NAFLD/NASH), viral hepatitis, alcohol use, metabolic conditions, or medication effects.

Key Takeaway

An indeterminate FIB-4 result means further evaluation is needed to clarify your liver fibrosis status. It does not confirm serious liver disease but suggests that monitoring and possibly additional testing are advisable.

The FIB-4 Index is a non-invasive scoring system used to estimate the degree of liver fibrosis, particularly in patients with chronic liver diseases like Hepatitis C and non-alcoholic fatty liver disease (NAFLD). It is calculated based on routine laboratory tests, incorporating the patient's age, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and platelet count. The formula is: [Age (years) x AST (U/L)] / [Platelet count (10^9/L) x sqrt(ALT (U/L))]. This index helps clinicians assess liver scarring without the need for a liver biopsy, thus providing a simpler, less invasive method for evaluating liver health. A higher FIB-4 score suggests a greater likelihood of significant fibrosis or cirrhosis, while a lower score indicates minimal fibrosis. It is particularly valuable in primary care and general clinical settings as a screening tool to identify patients who may need further hepatological evaluation or management. However, it's important to note that the FIB-4 Index is not definitive and may need to be complemented by other diagnostic methods, especially in borderline cases or populations with different underlying liver diseases.

FIB-4 Index
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond FIB-4 Index — 10,000+ markers explained
One FIB-4 Index result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro